Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing. The ...

Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, ...

Cannabix Technologies Inc.: Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the "Company" or "Cannabix") and Omega Laboratories, ...

FDA clears Visby Medical’s at-home Covid-19 and Influenza PCR test

Visby Medical’s over the counter (OTC) combination PCR test for Covid-19 and influenza A/B detection has secured US Food and ...
InvestorsHub on MSN

Cannabix expands breath testing potential with breakthrough detection of methamphetamine and amphetamine

Cannabix Technologies (CSE:BLO)(USOTC:BLOZF)(Frankfurt: 8CT)has announced a potentially transformative advancement in the ...
Drug Target Review

Drug development has changed. Bioanalysis is changing with it

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How is the field adapting to meet these new demands?
Technology Networks

Automated Quality Control: Accelerating Lot Release with PCR Assays

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
FierceBiotech

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx. Hernexeos was approved last August for previously ...

Accelerating Drug Discovery with AI and Next-Generation Automation

Accelerating Drug Discovery with AI and Next-Generation Automation The pharmaceutical industry is currently witnessi ...
BioSpace

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test

SINGAPORE, May 27, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S.
News Medical

Explainable AI could make breast cancer drug predictions safer and clearer

Study: AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework. Image Credit: ProStockStudio / Shutterstock In a recent review published in the journal npj ...